+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

South & Central America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

  • PDF Icon

    Report

  • March 2026
  • The Insight Partners
  • ID: 6284995
Description Jump to:
The South & Central America Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 730.3 million by 2031, up from US$ 533.2 million in 2024. This growth reflects a compound annual growth rate (CAGR) of 4.8% from 2025 to 2031. The market is primarily driven by increasing incidences of chronic diseases, trauma cases, and surgical procedures, which have heightened the demand for various blood components, including red blood cells, plasma, and platelets.

Government initiatives and public health campaigns aimed at promoting blood donation are playing a crucial role in enhancing donor awareness and participation. As the number of organ transplant procedures rises, the need for compatible donor blood becomes increasingly critical, underscoring the importance of blood donation in facilitating successful transplant outcomes. Additionally, collaborations between government bodies and non-profit organizations are improving outreach efforts to rural and underserved populations, further boosting blood donation rates. The aging population and rising healthcare expenditures are also contributing to sustained demand for blood components in the region.

### Market Segmentation Analysis

The South & Central America Donor Blood Component Market is segmented by various criteria:

  • **By Blood Component**: The market is divided into Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others. In 2024, Red Blood Cells held the largest market share.
  • **By Blood Component Volume**: Similar to the above, Red Blood Cells again dominated the market share in 2024.
  • **By Indication**: The market is categorized into Immunosuppression and Oncology, with Immunosuppression leading in market share in 2024.
  • **By Immunosuppression**: This segment includes Organ Transplant, HIV or AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others, with HIV or AIDS holding the largest share.
  • **By Oncology**: The market is divided into Hematologic malignancies and Solid Tumor Patients, where Hematologic malignancies had the largest share in 2024.
  • **By Application**: This includes Anemia management, Thrombocytopenia treatment, Coagulopathy correction, Supportive care during chemotherapy, Surgery, and Others, with Anemia management leading the market.
  • **By Age Group**: The market is segmented into Adult and Child, with Adults holding the largest share.
  • **By End User**: This includes Hospitals, Oncology centers, Transplant centers, Ambulatory surgical centers, and Others, with Hospitals dominating the market in 2024.
### Market Outlook
The future of the donor blood component market is being shaped by the rising demand for plasma-derived therapies. Advances in treatments for immune disorders and chronic diseases are increasing the need for plasma products. Growing awareness and technological improvements are driving higher rates of plasma collection and processing, which is expected to fuel market growth and innovation in the coming years.

According to the Pan American Health Organization (PAHO), there was a 15.5% increase in voluntary blood donations across Latin America and the Caribbean from 2020 to 2023, indicating a growing supply of plasma for therapies. Brazil, Colombia, and Argentina account for approximately 75% of the region's blood collections. Digital campaigns and mobile blood drives are anticipated to further increase donations by an additional 10% by 2026, aiming to meet the rising demand for plasma-derived therapies and improve access to treatment for immune and chronic diseases.

Strengthening plasma collection infrastructure is a key priority for healthcare systems in the region. The demand for plasma-derived therapies is driving significant growth and innovation in the donor blood component market. Efforts to improve plasma self-sufficiency and expand donor pools are gaining momentum globally, supported by technological advancements and strategic funding that enhance production capabilities and treatment accessibility.

### Country Insights
The market is segmented by country into Brazil, Argentina, and the Rest of South & Central America, with Brazil holding the largest market share in 2024. In 2022, Brazil reported 627,193 cancer cases, which necessitate frequent transfusions of blood components due to the effects of cancer therapies on bone marrow. The Brazilian Ministry of Health indicates that 1.9% of the population donates blood annually, resulting in approximately 4 million donations, with the public system accounting for about 70% of these donations. This reliable supply of blood supports the processing of components like red blood cells, platelets, and plasma, enabling healthcare providers to meet rising demand and reduce supply shortages.

In 2023, organ donations in Brazil facilitated 9,200 transplants, a 13% increase from the previous year. Organ transplantation requires substantial volumes of blood components, further driving demand as awareness and technology improve in this area. The increasing number of transplant surgeries highlights the critical role of blood donation in supporting successful medical outcomes.

Table of Contents

1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:
4. Donor Blood Component Market Landscape
4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024
5. South & Central America Donor Blood Component Market - Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:
6. Donor Blood Component Market - South & Central America Market Analysis
6.1 South & Central America Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 South & Central America Donor Blood Component Market Forecast and Analysis
7. South & Central America Donor Blood Component Market Revenue Analysis - by Blood Component
7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8. South & Central America Donor Blood Component Market Revenue Analysis - by Blood Component Volume
8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9. South & Central America Donor Blood Component Market Revenue Analysis - by Indication
9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10. South & Central America Donor Blood Component Market Revenue Analysis - by Immunosuppression
10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11. South & Central America Donor Blood Component Market Revenue Analysis - by Oncology
11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12. South & Central America Donor Blood Component Market Revenue Analysis - by Application
12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13. South & Central America Donor Blood Component Market Revenue Analysis - by Age Group
13.1 Adult
13.1.1 Overview
13.1.2 Adult: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14. South & Central America Donor Blood Component Market Revenue Analysis - by End User
14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15. South & Central America Donor Blood Component Market - Country Analysis
15.1 South & Central America
15.1.1 South & Central America Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 South & Central America Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 Brazil: South & Central America Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 Brazil: South & Central America Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 Brazil: South & Central America Donor Blood Component Market Share - by Indication
15.1.2.2.4 Brazil: South & Central America Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 Brazil: South & Central America Donor Blood Component Market Share - by Oncology
15.1.2.2.6 Brazil: South & Central America Donor Blood Component Market Share - by Application
15.1.2.2.7 Brazil: South & Central America Donor Blood Component Market Share - by Age Group
15.1.2.2.8 Brazil: South & Central America Donor Blood Component Market Share - by End User
15.2.3.3 Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 Argentina: South & Central America Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 Argentina: South & Central America Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 Argentina: South & Central America Donor Blood Component Market Share - by Indication
15.2.3.3.4 Argentina: South & Central America Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 Argentina: South & Central America Donor Blood Component Market Share - by Oncology
15.2.3.3.6 Argentina: South & Central America Donor Blood Component Market Share - by Application
15.2.3.3.7 Argentina: South & Central America Donor Blood Component Market Share - by Age Group
15.2.3.3.8 Argentina: South & Central America Donor Blood Component Market Share - by End User
15.3.4.4 Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Indication
15.3.4.4.4 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Oncology
15.3.4.4.6 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Application
15.3.4.4.7 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by Age Group
15.3.4.4.8 Rest of South & Central America: South & Central America Donor Blood Component Market Share - by End User
17 Industry Landscape
17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments
18 COMPANY PROFILES
18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments
19. Appendix
19.1 About the Analyst
LIST OF TABLES
Table 1. South & Central America Donor Blood Component Market Segmentation
Table 3. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
LIST OF FIGURES
Figure 1. South & Central America Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. South & Central America Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. South & Central America Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. South & Central America Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. South & Central America Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. South & Central America Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. South & Central America Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. South & Central America Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. South & Central America Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. South & Central America Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. South & Central America Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. South & Central America Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. Brazil: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. Argentina: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. Rest of South & Central America: South & Central America Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

Companies

The List of Companies - South & Central America Donor Blood Component Market

Vitalant

Memorial Sloan Kettering Cancer Center

Roswell Park Comprehensive Cancer Center

Policlinico of Milan

MD Anderson Cancer Center.

The Johns Hopkins Hospital

The Royal Marsden

Gustave Roussy

Peter MacCallum Cancer Centre

Tata Memorial Hospital

Related Topics

Related Reports

Donor Blood Components Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component, Indication, Application, Age Group, End User, and Geography - Product Image

Donor Blood Components Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component, Indication, Application, Age Group, End User, and Geography

  • Report
  • 342 Pages
  • Global
From
Asia-Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis - Product Image

Asia-Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

  • Report
  • Asia Pacific
From
Middle East & Africa Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis - Product Image

Middle East & Africa Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

  • Report
  • Africa, Middle East
From
North America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis - Product Image

North America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

  • Report
  • North America
From
Europe Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis - Product Image

Europe Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

  • Report
  • Europe
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.